These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38633448)

  • 1. Reticular Bullous Epithelial Corneal Edema after Netarsudil Use for Elevated Intraocular Pressure with Concurrent Fuchs Endothelial Corneal Dystrophy: A Case Report.
    Park KS; Lieu AC; Ang MJ; Afshari NA
    Case Rep Ophthalmol; 2024; 15(1):369-373. PubMed ID: 38633448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Netarsudil-associated reticular corneal epithelial edema.
    Tran JA; Jurkunas UV; Yin J; Davies EC; Sola-Del Valle DA; Chen TC; Lin MM
    Am J Ophthalmol Case Rep; 2022 Mar; 25():101287. PubMed ID: 35146185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reticular Bullous Epithelial Edema in Corneas Treated with Netarsudil: A Case Series.
    Wisely CE; Liu KC; Gupta D; Carlson AN; Asrani SG; Kim T
    Am J Ophthalmol; 2020 Sep; 217():20-26. PubMed ID: 32289295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two pediatric cases of reticular corneal epithelial edema associated with netarsudil.
    Guzman Aparicio MA; Liebman DL; Chodosh J; Freitag SK; Kazlas M; Mai DD; Marando CM; Mukai S; Wu AM; Chen TC
    Am J Ophthalmol Case Rep; 2022 Sep; 27():101638. PubMed ID: 35813588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized, Double-Masked, Pilot Study of Netarsudil 0.02% Ophthalmic Solution for Treatment of Corneal Edema in Fuchs Dystrophy.
    Price MO; Price FW
    Am J Ophthalmol; 2021 Jul; 227():100-105. PubMed ID: 33737034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase 2, Randomized, Open-Label Parallel-Group Study of Two Dosing Regimens of Netarsudil for the Treatment of Corneal Edema Due to Fuchs Corneal Dystrophy.
    Lindstrom RL; Lewis AE; Holland EJ; Sheppard JD; Hovanesian JA; Senchyna M; Hollander DA
    J Ocul Pharmacol Ther; 2022 Dec; 38(10):657-663. PubMed ID: 36327101
    [No Abstract]   [Full Text] [Related]  

  • 7. Transient Reticular Cystic Corneal Epithelial Edema With Topical Netarsudil: A Case Series and Review.
    LoBue SA; Moustafa GA; Vu A; Amin M; Nguyen T; Goyal H
    Cornea; 2021 Aug; 40(8):1048-1054. PubMed ID: 33369939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot Study of Corneal Clearance With the Use of a Rho-Kinase Inhibitor After Descemetorhexis Without Endothelial Keratoplasty for Fuchs Endothelial Corneal Dystrophy.
    Davies E; Jurkunas U; Pineda R
    Cornea; 2021 Jul; 40(7):899-902. PubMed ID: 33758139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Netarsudil-associated epithelial keratopathy.
    Ramakrishnan MS; Addis VM; Lehman AY; Sankar PS
    Am J Ophthalmol Case Rep; 2020 Sep; 19():100800. PubMed ID: 32637736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reticular epithelial edema after penetrating keratoplasty in a patient taking netarsudil.
    Jeang LJ; Shah AS; Hammer JD; Tuli SS
    Digit J Ophthalmol; 2022; 28(8):34-37. PubMed ID: 35854963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reticular Epithelial Edema: An Uncommon Side Effect of ROCK/NET Inhibitor Netarsudil.
    Chen H; McMillin JC; Frankfort BJ; Al-Mohtaseb Z
    J Glaucoma; 2020 Nov; 29(11):e124-e126. PubMed ID: 32826765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reticular Corneal Edema or Corneal Honeycombing in Eyes Treated With Netarsudil: A Case Series.
    Moumneh K; Sheybani A; Fellman RL; Godfrey DG; Grover DS
    J Glaucoma; 2020 Jul; 29(7):607-610. PubMed ID: 32398584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case report: The use of netarsudil to improve corneal edema after laser peripheral iridotomy and Descemet's membrane endothelial keratoplasty.
    Chen SL; LoBue SA; Goyal H
    Am J Ophthalmol Case Rep; 2021 Jun; 22():101087. PubMed ID: 33997467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reticular epithelial corneal edema as a novel side-effect of Rho Kinase Inhibitors: An Indian scenario.
    Bhargava M; Sen S; Bhambhani V; Paul RS; Dutta C
    Indian J Ophthalmol; 2022 Apr; 70(4):1163-1170. PubMed ID: 35326007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reticular corneal epithelial edema with topical netarsudil.
    Parmar DP; Bhole PK; Garde PV
    Oman J Ophthalmol; 2023; 16(1):94-97. PubMed ID: 37007228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible Corneal Endothelial Abnormalities With Netarsudil.
    Tanna AP; Esfandiari H; Teramoto K
    J Glaucoma; 2020 Jun; 29(6):e41-e43. PubMed ID: 32224803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case Series: Novel Utilization of Rho-Kinase Inhibitor for the Treatment of Corneal Edema.
    Davies E
    Cornea; 2021 Jan; 40(1):116-120. PubMed ID: 33269892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Rho Kinase Inhibitors in Corneal Diseases.
    Futterknecht S; Chatzimichail E; Gugleta K; Panos GD; Gatzioufas Z
    Drug Des Devel Ther; 2024; 18():97-108. PubMed ID: 38264539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual corneal involvement by endothelial and epithelial corneal dystrophies in Steinert's disease: A case of triple dystrophy.
    Gargallo-Benedicto A; Pérez-Torregrosa VT; Clemente-Tomás R; Duch-Samper AM
    Eur J Ophthalmol; 2021 Mar; 31(2):NP23-NP26. PubMed ID: 31476892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Rapid and reversible alteration in corneal contour and power associated with Netarsudil/Latanoprost".
    Chung D; Meier EJ
    Am J Ophthalmol Case Rep; 2022 Jun; 26():101501. PubMed ID: 35387385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.